Wednesday, March 29, 2023
Clinical Advances
Read Overview
Supported by an independent educational grant from
Steering Committee Chair
Professor of Medicine, University Hospital of Salamanca, Salamanca, Spain
Professor, Head of Myeloma Clinic
Department of Haematology
Hospital La Miletrie
Poitiers, France
Professor, Emory University, Atlanta, Georgia, United States, The opinions expressed are those of Dr Lonial and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Lonialâs participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Professor, Department of Ophthalmology, University of Münich, München, Germany
Professor, Consultant Hematologist, University College London Hospitals, NHS Foundation Trust, London, United Kingdom
Associate Professor of Hematology, Amsterdam University Medical Center, location VU University Medical Center, Amsterdam, the Netherlands
Steering Committee Chair
Has disclosed the following financial relationships:
Served as an advisor or consultant for: AbbVie; Adaptive; Amgen; Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Regeneron; Takeda
Served as a speaker or a member of a speakers bureau for: Adaptive; Amgen; Celgene; GlaxoSmithKline; Janssen; Takeda
Steering Committee Member
Has disclosed the following financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; Bristol Myers Squibb Company; Gilead; Incyte; Janssen; Karyopharm; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; Bristol Myers Squibb Company; Celgene; GlaxoSmithKline; Janssen; Novartis; Takeda
Received grants for clinical research from: Bristol Myers Squibb Company; Celgene; Janssen; Takeda
Owns stock, stock options, or bonds from: Board of Directors: TG Therapeutics
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alcon; DMG; Dompé; Kala; Novartis; Pharm-Allergan GmbH; Santen GmbH; Shire; Sun; Sifi; Théa Pharma GmbH; TRB-Chemedica AG; Visufarma
Served as a speaker or a member of a speakers bureau for: Alcon; Dompé; Novartis; Pharm-Allergan GmbH; Santen GmbH; Shire; Théa Pharma GmbH; TRB-Chemedica AG; Ursapharm; Visufarma
Received grants for clinical research from: Chiesi
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Celgene; GlaxoSmithKline; Janssen
Served as a speaker or a member of a speakers bureau for: AbbVie; Janssen; Takeda
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Amgen; Bayer; Bristol Myers Squibb Company; Celgene; Janssen; Novartis; Takeda
Received grants for clinical research from: Amgen; Bristol Myers Squibb Company; Celgene; Janssen
